Cargando…

Primary Graft Dysfunction: The Role of Aging in Lung Ischemia-Reperfusion Injury

Transplant centers around the world have been using extended criteria donors to remedy the ongoing demand for lung transplantation. With a rapidly aging population, older donors are increasingly considered. Donor age, at the same time has been linked to higher rates of lung ischemia reperfusion inju...

Descripción completa

Detalles Bibliográficos
Autores principales: Roesel, Maximilian J., Sharma, Nirmal S., Schroeter, Andreas, Matsunaga, Tomohisa, Xiao, Yao, Zhou, Hao, Tullius, Stefan G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170999/
https://www.ncbi.nlm.nih.gov/pubmed/35686120
http://dx.doi.org/10.3389/fimmu.2022.891564
_version_ 1784721562151157760
author Roesel, Maximilian J.
Sharma, Nirmal S.
Schroeter, Andreas
Matsunaga, Tomohisa
Xiao, Yao
Zhou, Hao
Tullius, Stefan G.
author_facet Roesel, Maximilian J.
Sharma, Nirmal S.
Schroeter, Andreas
Matsunaga, Tomohisa
Xiao, Yao
Zhou, Hao
Tullius, Stefan G.
author_sort Roesel, Maximilian J.
collection PubMed
description Transplant centers around the world have been using extended criteria donors to remedy the ongoing demand for lung transplantation. With a rapidly aging population, older donors are increasingly considered. Donor age, at the same time has been linked to higher rates of lung ischemia reperfusion injury (IRI). This process of acute, sterile inflammation occurring upon reperfusion is a key driver of primary graft dysfunction (PGD) leading to inferior short- and long-term survival. Understanding and improving the condition of older lungs is thus critical to optimize outcomes. Notably, ex vivo lung perfusion (EVLP) seems to have the potential of reconditioning ischemic lungs through ex-vivo perfusing and ventilation. Here, we aim to delineate mechanisms driving lung IRI and review both experimental and clinical data on the effects of aging in augmenting the consequences of IRI and PGD in lung transplantation.
format Online
Article
Text
id pubmed-9170999
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91709992022-06-08 Primary Graft Dysfunction: The Role of Aging in Lung Ischemia-Reperfusion Injury Roesel, Maximilian J. Sharma, Nirmal S. Schroeter, Andreas Matsunaga, Tomohisa Xiao, Yao Zhou, Hao Tullius, Stefan G. Front Immunol Immunology Transplant centers around the world have been using extended criteria donors to remedy the ongoing demand for lung transplantation. With a rapidly aging population, older donors are increasingly considered. Donor age, at the same time has been linked to higher rates of lung ischemia reperfusion injury (IRI). This process of acute, sterile inflammation occurring upon reperfusion is a key driver of primary graft dysfunction (PGD) leading to inferior short- and long-term survival. Understanding and improving the condition of older lungs is thus critical to optimize outcomes. Notably, ex vivo lung perfusion (EVLP) seems to have the potential of reconditioning ischemic lungs through ex-vivo perfusing and ventilation. Here, we aim to delineate mechanisms driving lung IRI and review both experimental and clinical data on the effects of aging in augmenting the consequences of IRI and PGD in lung transplantation. Frontiers Media S.A. 2022-05-24 /pmc/articles/PMC9170999/ /pubmed/35686120 http://dx.doi.org/10.3389/fimmu.2022.891564 Text en Copyright © 2022 Roesel, Sharma, Schroeter, Matsunaga, Xiao, Zhou and Tullius https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Roesel, Maximilian J.
Sharma, Nirmal S.
Schroeter, Andreas
Matsunaga, Tomohisa
Xiao, Yao
Zhou, Hao
Tullius, Stefan G.
Primary Graft Dysfunction: The Role of Aging in Lung Ischemia-Reperfusion Injury
title Primary Graft Dysfunction: The Role of Aging in Lung Ischemia-Reperfusion Injury
title_full Primary Graft Dysfunction: The Role of Aging in Lung Ischemia-Reperfusion Injury
title_fullStr Primary Graft Dysfunction: The Role of Aging in Lung Ischemia-Reperfusion Injury
title_full_unstemmed Primary Graft Dysfunction: The Role of Aging in Lung Ischemia-Reperfusion Injury
title_short Primary Graft Dysfunction: The Role of Aging in Lung Ischemia-Reperfusion Injury
title_sort primary graft dysfunction: the role of aging in lung ischemia-reperfusion injury
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170999/
https://www.ncbi.nlm.nih.gov/pubmed/35686120
http://dx.doi.org/10.3389/fimmu.2022.891564
work_keys_str_mv AT roeselmaximilianj primarygraftdysfunctiontheroleofaginginlungischemiareperfusioninjury
AT sharmanirmals primarygraftdysfunctiontheroleofaginginlungischemiareperfusioninjury
AT schroeterandreas primarygraftdysfunctiontheroleofaginginlungischemiareperfusioninjury
AT matsunagatomohisa primarygraftdysfunctiontheroleofaginginlungischemiareperfusioninjury
AT xiaoyao primarygraftdysfunctiontheroleofaginginlungischemiareperfusioninjury
AT zhouhao primarygraftdysfunctiontheroleofaginginlungischemiareperfusioninjury
AT tulliusstefang primarygraftdysfunctiontheroleofaginginlungischemiareperfusioninjury